MLTX vs. SMCI
MLTX (MoonLake Immunotherapeutics) and SMCI (Super Micro Computer, Inc.) are both stocks. MLTX operates in Biotechnology (Healthcare), while SMCI operates in Computer Hardware (Technology). Over the past 5 years, MLTX returned 13.20%/yr vs 49.93%/yr for SMCI. Their 0.12 correlation means their historical movements had little consistent relationship.
Performance
MLTX vs. SMCI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MLTX achieves a 39.91% return, which is significantly higher than SMCI's -2.15% return.
MLTX
- 1D
- -2.90%
- 1M
- -2.69%
- 6M
- 17.68%
- YTD
- 39.91%
- 1Y
- -65.15%
- 3Y*
- -31.69%
- 5Y*
- 13.20%
- 10Y*
- —
- ALL TIME*
- 10.87%
SMCI
- 1D
- 0.85%
- 1M
- 5.22%
- 6M
- -3.60%
- YTD
- -2.15%
- 1Y
- -49.44%
- 3Y*
- -5.38%
- 5Y*
- 49.93%
- 10Y*
- 29.57%
- ALL TIME*
- 19.69%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $16.11M | $20.69M | $21.49M | |
| $1.64B | $1.20B | $1.80B |
MLTX vs. SMCI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
MLTX MoonLake Immunotherapeutics | 39.91% | -75.66% | -10.33% | 475.14% | 6.17% | -13.02% | 11.91% |
SMCI Super Micro Computer, Inc. | -2.15% | -3.97% | 7.23% | 246.24% | 86.80% | 38.82% | 18.62% |
Correlation
The correlation between MLTX and SMCI is 0.22, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.22 |
Correlation (3Y) Balances recent behavior with more history. | 0.13 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.12 |
Correlation (All Time) Calculated using the full available price history since Oct 20, 2020 | 0.12 |
The correlation between MLTX and SMCI shifts across timeframes, from 0.12 (5 years) to 0.22 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
MLTX:
$1.55B
SMCI:
$18.53B
MLTX:
-$3.85
SMCI:
$2.66
MLTX:
5.17
SMCI:
2.55
MLTX:
$0.00
SMCI:
$33.70B
MLTX:
-$1.49M
SMCI:
$2.83B
MLTX:
-$179.84M
SMCI:
$1.47B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MLTX vs. SMCI — Risk / Return Rank
MLTX
SMCI
MLTX vs. SMCI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for MoonLake Immunotherapeutics (MLTX) and Super Micro Computer, Inc. (SMCI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MLTX | SMCI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.01 | ||
| Sortino ratioReturn per unit of downside risk | +1.08 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 0.95 | +0.21 |
| Calmar ratioReturn relative to maximum drawdown | -0.71 | -0.76 | +0.06 |
| Martin ratioReturn relative to average drawdown | -0.93 | -1.18 | +0.25 |
Loading charts...
Drawdowns
MLTX vs. SMCI - Drawdown Comparison
The maximum MLTX drawdown since its inception was -90.22%, which is greater than SMCI's maximum drawdown of -84.84%. Use the drawdown chart below to compare losses from any high point for MLTX and SMCI.
Loading charts...
Drawdown Indicators
| MLTX | SMCI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.22% | -84.84% | -5.38% |
Max Drawdown (1Y)Largest decline over 1 year | -89.93% | -65.01% | -24.92% |
Max Drawdown (3Y)Largest decline over 3 years | -90.22% | -84.84% | -5.38% |
Max Drawdown (5Y)Largest decline over 5 years | -90.22% | -84.84% | -5.38% |
Max Drawdown (10Y)Largest decline over 10 years | — | -84.84% | — |
Current DrawdownCurrent decline from peak | -71.12% | -75.89% | +4.77% |
Average DrawdownAverage peak-to-trough decline | -30.25% | -32.29% | +2.04% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 68.46% | 42.10% | +26.36% |
Volatility
MLTX vs. SMCI - Volatility Comparison
The current volatility for MoonLake Immunotherapeutics (MLTX) is 16.02%, while Super Micro Computer, Inc. (SMCI) has a volatility of 27.78%. This indicates that MLTX experiences smaller price fluctuations and is considered to be less risky than SMCI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MLTX | SMCI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.02% | 27.78% | -11.76% |
Volatility (6M)Calculated over the trailing 6-month period | 42.92% | 82.11% | -39.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 117.23% | 89.80% | +27.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 91.77% | 88.04% | +3.73% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 85.91% | 71.51% | +14.40% |
Dividends
MLTX vs. SMCI - Dividend Comparison
Neither MLTX nor SMCI has paid dividends to shareholders.
Financials
MLTX vs. SMCI - Financials Comparison
This section allows you to compare key financial metrics between MoonLake Immunotherapeutics and Super Micro Computer, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MLTX and SMCI have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SMCI has higher volatility (27.78%) compared to MLTX (16.02%). In terms of maximum drawdown, MLTX dropped -90.22% vs SMCI's -84.84%.
MLTX currently has the higher Sharpe Ratio (-0.54 vs -0.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MLTX and SMCI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer